loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Certificates of Suitability (CEPs) for r0_cep_2016_239___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CAD MIDDLE EAST PHARMACEUTICAL INDUSTRIES LLC Riyadh SA (1)

filter

01 Clopidogrel hydrogen sulfate (1)

filter

01 Saudi Arabia (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2016-239 - Rev 00
Withdrawn by Holder
Chemical
2018-12-20
2023-12-06
2531
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2016-239 - Rev 00 of Cad Middle East Pharmaceutical Industries Llc Riyadh Sa

Looking for Certificates of Suitability (CEPs) for R0-CEP 2016-239 - Rev 00 of Cad Middle East Pharmaceutical Industries Llc Riyadh Sa 1

20

Cad Middle East Pharmaceutical Industries Llc Riyadh Sa, based in Saudi Arabia, is a pharmaceutical company.

One of their significant offerings is Clopidogrel hydrogen sulfate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2016-239 - Rev 00

This Chemical Type CEP, issued on December 20, 2018, remains in force until December 06, 2023, ensuring its reliability within the pharmaceutical industry.

Substance Number 2531 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY